| -Caveat Lector-
Of course Prozac is in the same category with the same effects. What is a
suicide "gesture?" Is that the same thing as trying to kill yourself? - JR
FDA Statement Regarding the Anti-Depressant Paxil for Pediatric Population
It has come to our attention that the Food and Drug Administration (FDA) has issued a warning about the use of Paxil for people younger than 18 years of age. Paxil is one of the drugs in a class of medicines called Selective Serotonin Reuptake Inhibitors (SSRIs) that are used to treat persons suffering from major depressive disorder (MDD), and other disorders. The drug has not been approved by the FDA for pediatric use in treating depression. According to the FDA there currently is "no evidence that Paxil is effective in children or adolescents" with MDD. The only drug approved by the FDA for treating depression in children is Prozac. For some children Paxil may be appropriate. In June 2003 the FDA warned that patients under age 18 should not take
Paxil because of possible increased risk of self-harm and suicidal impulses
associated with the drug. The FDA is currently reviewing reports and clinical
trials showing an increased risk of suicidal behavior related to the use of
Paxil in children and adolescents. Although the FDA has not completed this
evaluation, they are recommending that Paxil not be used in the treatment of
pediatric MDD.
IT IS VERY IMPORTANT THAT
CHILDREN AND ADOLESCENTS DO NOT STOP TAKING PAXIL SUDDENLY!
Paxil can cause significant reactions when
being discontinued. Adverse effects include shivering; feeling nauseated,
disoriented, or anxious; and, at times, increases in impulsive behavior
including suicidal ideation, plan and gestures. The
FDA's statement is that "caretakers of pediatric patients already receiving
treatment with Paxil for MDD talk to their doctor before stopping use of the
drug. Patients should not discontinue use of Paxil without first consulting
their physicians, and it is important that Paxil not be abruptly discontinued."
In response to this warning from the FDA, the Children�s Administration is
taking the following four actions: 1. The Children�s Administration is directing all children in our care
receiving Paxil to have a medical review with the prescribing physician. If the
prescribing physician recommends maintenance on Paxil you are to seek a second
opinion. To accomplish this we are taking these steps:
2. There should be no new prescriptions of Paxil for children in the
Department�s custody until the FDA clarifies issues with the drug. Social workers should not consent to, or recommend the court approve any
new prescriptions of Paxil for children in the Department�s custody without a
second opinion and the approval of the Regional Administrator. 3. Informational letters will be sent to parents of identified children who
have been returned home, or are receiving adoption support services. Letters will be sent from Headquarters to the parents of identified
children whose cases are closed, or are receiving adoption support. A copy of
the letter will be sent to the region for the child�s file. 4. Attached are an FDA �Talk Paper�, and helpful Questions and Answers on
Paxil. This information will also be posted on the foster parent web site.
Let us please be civil and as always, Caveat Lector. ======================================================================== Archives Available at: http://www.mail-archive.com/[EMAIL PROTECTED]/ <A HREF="">ctrl</A> ======================================================================== To subscribe to Conspiracy Theory Research List[CTRL] send email: SUBSCRIBE CTRL [to:] [EMAIL PROTECTED] To UNsubscribe to Conspiracy Theory Research List[CTRL] send email: SIGNOFF CTRL [to:] [EMAIL PROTECTED] Om | |||||||||||||||||||||||||||
